ADT
Advertisement
Researchers performed a meta-analysis to compare abiraterone and abiraterone plus apalutamide—both with androgen ...
Piflufolastat F 18 is a radiopharmaceutical that targets the prostate-specific membrane antigen during imaging.
Inflammation due to treatment with androgen deprivation therapy (ADT) may be the cause of increased fatigue in patients ...
Prolonged androgen deprivation therapy (ADT) was found to impair cardiorespiratory fitness and increase risk of ...
A study compared dementia risk among prostate cancer patients receiving different types of androgen deprivation therapy ...
A randomized trial published in JAMA Oncology compared outcomes between stereotactic ablative radiotherapy (SABR) versus ...
A study examined functional outcomes over five years correlated with five different treatments for localized prostate ...
The U.S. Food and Drug Administration expanded the approval of Erleada® (apalutamide) to include the treatment of men ...
Men with advanced prostate cancer may have better outcomes when treated surgically followed by radiotherapy (XRT) than ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.